Literature DB >> 26608914

Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.

Rocky L Baker1, Brenda Bradley1, Timothy A Wiles1, Robin S Lindsay1, Gene Barbour1, Thomas Delong1, Rachel S Friedman1, Kathryn Haskins2.   

Abstract

T cells reactive to β cell Ags are critical players in the development of autoimmune type 1 diabetes. Using a panel of diabetogenic CD4 T cell clones derived from the NOD mouse, we recently identified the β cell secretory granule protein, chromogranin A (ChgA), as a new autoantigen in type 1 diabetes. CD4 T cells reactive to ChgA are pathogenic and rapidly transfer diabetes into young NOD recipients. We report in this article that NOD.ChgA(-/-) mice do not develop diabetes and show little evidence of autoimmunity in the pancreatic islets. Using tetramer analysis, we demonstrate that ChgA-reactive T cells are present in these mice but remain naive. In contrast, in NOD.ChgA(+/+) mice, a majority of the ChgA-reactive T cells are Ag experienced. Our results suggest that the presence of ChgA and subsequent activation of ChgA-reactive T cells are essential for the initiation and development of autoimmune diabetes in NOD mice.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26608914      PMCID: PMC4684982          DOI: 10.4049/jimmunol.1501190

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  IA-2 is not required for the development of diabetes in NOD mice.

Authors:  A Kubosaki; J Miura; Abner L Notkins
Journal:  Diabetologia       Date:  2003-11-12       Impact factor: 10.122

2.  Cutting edge: type 1 diabetes occurs despite robust anergy among endogenous insulin-specific CD4 T cells in NOD mice.

Authors:  Kristen E Pauken; Jonathan L Linehan; Justin A Spanier; Nathanael L Sahli; Lokesh A Kalekar; Bryce A Binstadt; James J Moon; Daniel L Mueller; Marc K Jenkins; Brian T Fife
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

3.  An evolving autoimmune microenvironment regulates the quality of effector T cell restimulation and function.

Authors:  Rachel S Friedman; Robin S Lindsay; Jason K Lilly; Vinh Nguyen; Caitlin M Sorensen; Jordan Jacobelli; Matthew F Krummel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-10       Impact factor: 11.205

4.  Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis.

Authors:  Andreas Lutterotti; Sara Yousef; Andreas Sputtek; Klarissa H Stürner; Jan-Patrick Stellmann; Petra Breiden; Stefanie Reinhardt; Christian Schulze; Maxim Bester; Christoph Heesen; Sven Schippling; Stephen D Miller; Mireia Sospedra; Roland Martin
Journal:  Sci Transl Med       Date:  2013-06-05       Impact factor: 17.956

5.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

Authors:  Thomas Stratmann; Natalia Martin-Orozco; Valérie Mallet-Designe; Laurent Poirot; Dorian McGavern; Grigoriy Losyev; Cathleen M Dobbs; Michael B A Oldstone; Kenji Yoshida; Hitoshi Kikutani; Diane Mathis; Christophe Benoist; Kathryn Haskins; Luc Teyton
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

6.  Pancreatic islet-specific T-cell clones from nonobese diabetic mice.

Authors:  K Haskins; M Portas; B Bergman; K Lafferty; B Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice.

Authors:  Rocky L Baker; Thomas Delong; Gene Barbour; Brenda Bradley; Maki Nakayama; Kathryn Haskins
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

8.  Chromogranin A is a T cell antigen in human type 1 diabetes.

Authors:  Peter A Gottlieb; Thomas Delong; Rocky L Baker; Lisa Fitzgerald-Miller; Rebecca Wagner; Gabrielle Cook; Marian R Rewers; Aaron Michels; Kathryn Haskins
Journal:  J Autoimmun       Date:  2013-11-13       Impact factor: 7.094

9.  Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice.

Authors:  T Yamamoto; E Yamato; F Tashiro; T Sato; S Noso; H Ikegami; S Tamura; Y Yanagawa; J-I Miyazaki
Journal:  Diabetologia       Date:  2003-12-16       Impact factor: 10.122

10.  T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes.

Authors:  Mary E Pauza; Cathleen M Dobbs; Jing He; Tricia Patterson; Steven Wagner; Brian S Anobile; Brenda J Bradley; David Lo; Kathryn Haskins
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

View more
  24 in total

Review 1.  HIPs and HIP-reactive T cells.

Authors:  T A Wiles; T Delong
Journal:  Clin Exp Immunol       Date:  2019-06-17       Impact factor: 4.330

Review 2.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

3.  Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetes.

Authors:  Rocky L Baker; Braxton L Jamison; Kathryn Haskins
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-08       Impact factor: 3.243

4.  A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery.

Authors:  Baoyu Liu; Jennifer D Hood; Elizabeth M Kolawole; Derek M Woodruff; Dario A Vignali; Maria Bettini; Brian D Evavold
Journal:  Diabetes       Date:  2019-12-05       Impact factor: 9.461

5.  CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse.

Authors:  Rocky L Baker; Braxton L Jamison; Timothy A Wiles; Robin S Lindsay; Gene Barbour; Brenda Bradley; Thomas Delong; Rachel S Friedman; Maki Nakayama; Kathryn Haskins
Journal:  Diabetes       Date:  2018-07-05       Impact factor: 9.461

Review 6.  Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.

Authors:  L Peters; A Posgai; T M Brusko
Journal:  Clin Exp Immunol       Date:  2019-08-14       Impact factor: 4.330

7.  Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.

Authors:  Catia S Verbeke; Susana Gordo; David A Schubert; Sarah A Lewin; Rajiv M Desai; Jessica Dobbins; Kai W Wucherpfennig; David J Mooney
Journal:  Adv Healthc Mater       Date:  2017-01-24       Impact factor: 9.933

Review 8.  Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".

Authors:  Sally C Kent; Stuart I Mannering; Aaron W Michels; Jenny Aurielle B Babon
Journal:  Curr Diab Rep       Date:  2017-09-02       Impact factor: 4.810

9.  Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.

Authors:  E Nikoopour; O Krougly; E Lee-Chan; S M Haeryfar; B Singh
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

10.  Silencing of high-affinity insulin-reactive B lymphocytes by anergy and impact of the NOD genetic background in mice.

Authors:  Mia J Smith; Rochelle M Hinman; Andrew Getahun; Soojin Kim; Thomas A Packard; John C Cambier
Journal:  Diabetologia       Date:  2018-09-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.